SUVICA
Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer. Currently, they have a small molecule protein synthesis inhibitor in pre-clinical development. SVC112 – With a patent filed for Composition of Matter protection, SVC112 has shown pre-clinical efficacy as monotherapy and in combination with standard therapies such as radiation and newly approved targeted agents. SVC112 is in pre-clinical development for a variety of cancer indications, including head & neck cancer, melanoma, colorectal cancer, and non-small cell lung cancer. It was founded in 2010 and is headquartered in Boulder, Colorado.
SUVICA
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2010-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.suvica.com
Total Employee:
1+
Status:
Active
Contact:
303-921-6680
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Organization Schema Apache Google Apps For Business Unified Layer ContactPoint Schema
Similar Organizations
Alef Biotechnology
Alef Biotechnology focused on the development of Medical Grade Cannabis products for the treatment of various medical conditions.
ASC Therapeutics
ASC Therapeutics is a biotechnology company that focuses on discovering and developing cures for intractable diseases.
BW Therapeutics
Founded in 2019 as a biotechnology company focused on the development of TYN-21, a 505(b)(2) formulation of Abraxane.
GliaMed
GliaMed is a development-stage biopharmaceutical company dedicated to the discovery and development of small molecule drugs which enhance
MangoGen Pharma
MangoGen is a biotechnology company that engages in the research and development of gene delivering cardiac stents and wound healing creams.
NodThera
NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.
Pennsylvania Biotechnology Association
Pennsylvania Biotechnology Association attests to the tensile strength of this region as a world-class biopharmaceutical center.
VIA Pharmaceuticals
VIA Pharmaceuticals is a biotechnology company focused on the development of small-molecule drugs to treat cardiovascular diseases.
Virginia Catalyst
Virginia Catalyst is a nonprofit corporation focusing on economic development through life sciences discoveries.
Current Employees Featured
Founder
Official Site Inspections
http://www.suvica.com Semrush global rank: 15.76 M Semrush visits lastest month: 46
- Host name: 192-254-236-52.unifiedlayer.com
- IP address: 192.254.236.52
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Suvica"
SuviCa’s Management Team
Mrs. Petro is a graduate of CU Denver, MBA (Finance), MS (Management & Organization). ... SuviCa Scientists Co-author a Paper on SuviCa’s lead compound; SuviCa Awarded a Phase II …See details»
Suvica - Crunchbase Company Profile & Funding
Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer. Currently, they …See details»
SuviCa Company Profile 2024: Valuation, Funding & Investors
SuviCa General Information Description. Developer of small molecules discovery platform designed for cancer treatment. The company's platform develops a compound that targets an …See details»
SuviCa, Inc. Company Profile | Estes Park, CO - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SuviCa, Inc. of Estes Park, CO. Get the latest business insights from Dun & Bradstreet.See details»
SuviCa, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore SuviCa, Inc. with its drug pipeline, therapeutic area, technology platform, 5 literature, Disease Domain:Neoplasms, Technology Platform:Small molecule drug ...See details»
SuviCa - Overview, News & Similar companies | ZoomInfo.com
Who is SuviCa. SuviCa, Inc. is focused on the discovery and development of small molecules for the treatment of cancer. Founded in 2010, Suvica, Inc. is focused o n the discovery and …See details»
SuviCA - Products, Competitors, Financials, Employees, …
SuviCa, Inc. is focused on the discovery and development of small molecules for the treatment of cancer. The company's main offerings include pre-clinical development of a small molecule …See details»
SUVICA, INC. - VentureRadar
Suvica is focused on the discovery and development of small molecule cancer therapeutics targeting a unique mechanism of action. SuviCa identifies potential candidates through …See details»
SuviCa Company Profile | Management and Employees List
Find contact information for SuviCa. Learn about their Manufacturing market share, competitors, and SuviCa's email format.See details»
SuviCa - Company Profile - Tracxn
SuviCa - Dveloping a novel small molecule drug to treat head and neck cancer. Founded by Scott Norviel and Tin Tin Su in the year 2010. SuviCa has 2847 competitors.See details»
Suvica - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer. Search Crunchbase. Start Free Trial . Chrome …See details»
SUVICA, INC. - Overview, Competitors, and Employees - Apollo.io
Suvica is a biotechnology company that is focused on the discovery and development of small molecules for the treatment of cancer. Currently, they have a small molecule protein synthesis …See details»
Tin Tin Su - CSO & Co-Founder at SuviCa - The Org
Su co-founded SuviCa. She also devised and patented a whole-animal screening technology to quickly and efficiently identify potential drug candidates. Dr. Su is an expert in radiation biology …See details»
Suvica - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Suvica . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Contacts 2. ... Suvica has 4 current …See details»
Partnering & Business Opportunities | SuviCa
SuviCa’s technology has been recognized as important by scientific and business reviewers at state and federal bodies who have provided financial support. The ideal partner(s) would be an …See details»
News & Releases - SuviCa
A manuscript entitled ‘Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma’ and co-authored by …See details»
SuviCA Management Team - CB Insights
Explore {SuviCA's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Our Technology - SuviCa
SuviCa is taking advantage of this under-utilized area to develop drugs to target hematological and solid tumors. For a recent publication, please visit …See details»
Product Pipeline - SuviCa
SuviCa’s Pipeline. Currently, SuviCa has a small molecule protein synthesis inhibitor in pre-clinical development. SVC112 – With a patent filed for Composition of Matter protection, …See details»